modelC07AB02

Diagram of C07AB02

Extends from Pharmacokinetic.Models.PK_2C_enteral.

Information

name:Metoprolol
ATC code:C07AB02
route:oral
compartments:2
dosage:100mg
volume of distribution:5.5L
clearance:124mL/min
other parameters in model implementation

Metoprolol is a selective β1-adrenergic receptor blocker used primarily to treat high blood pressure, angina, heart failure, and to prevent myocardial infarction. It is widely approved for clinical use and is available in both immediate-release and extended-release formulations.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adult volunteers following oral administration of immediate-release metoprolol tartrate.

References

  1. Zamir, A, et al., & Rasool, MF (2022). Clinical Pharmacokinetics of Metoprolol: A Systematic Review. Clinical pharmacokinetics 61(8) 1095–1114. DOI:10.1007/s40262-022-01145-y PUBMED:https://pubmed.ncbi.nlm.nih.gov/35764772

  2. Shimizu, H, et al., & Uno, K (1992). Variation of pharmacokinetics after oral administration of slow-release metoprolol tablets and pharmacogenetic considerations. Arzneimittel-Forschung 42(6) 802–806. PUBMED:https://pubmed.ncbi.nlm.nih.gov/1418033

  3. Huang, J, et al., & Lai, ML (1999). Pharmacokinetics of metoprolol enantiomers in Chinese subjects of major CYP2D6 genotypes. Clinical pharmacology and therapeutics 65(4) 402–407. DOI:10.1016/S0009-9236(99)70134-7 PUBMED:https://pubmed.ncbi.nlm.nih.gov/10223777

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance
Pharmacolibrary.Types.TransferRateka (from PK_2C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_2C_enteral)600delay between oral administration and absorption (default 10min)

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)